JP2022516710A5 - - Google Patents

Info

Publication number
JP2022516710A5
JP2022516710A5 JP2021537208A JP2021537208A JP2022516710A5 JP 2022516710 A5 JP2022516710 A5 JP 2022516710A5 JP 2021537208 A JP2021537208 A JP 2021537208A JP 2021537208 A JP2021537208 A JP 2021537208A JP 2022516710 A5 JP2022516710 A5 JP 2022516710A5
Authority
JP
Japan
Application number
JP2021537208A
Other languages
Japanese (ja)
Other versions
JPWO2020142780A5 (https=
JP2022516710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/012417 external-priority patent/WO2020142780A1/en
Publication of JP2022516710A publication Critical patent/JP2022516710A/ja
Publication of JPWO2020142780A5 publication Critical patent/JPWO2020142780A5/ja
Publication of JP2022516710A5 publication Critical patent/JP2022516710A5/ja
Pending legal-status Critical Current

Links

JP2021537208A 2019-01-06 2020-01-06 Car t細胞の方法及び構築物 Pending JP2022516710A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962788894P 2019-01-06 2019-01-06
US62/788,894 2019-01-06
PCT/US2020/012417 WO2020142780A1 (en) 2019-01-06 2020-01-06 Car t cell methods and constructs

Publications (3)

Publication Number Publication Date
JP2022516710A JP2022516710A (ja) 2022-03-02
JPWO2020142780A5 JPWO2020142780A5 (https=) 2023-01-19
JP2022516710A5 true JP2022516710A5 (https=) 2023-01-19

Family

ID=71406633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537208A Pending JP2022516710A (ja) 2019-01-06 2020-01-06 Car t細胞の方法及び構築物

Country Status (13)

Country Link
US (1) US20220090132A1 (https=)
EP (1) EP3906311A4 (https=)
JP (1) JP2022516710A (https=)
KR (1) KR20210137427A (https=)
CN (1) CN113382741A (https=)
AU (1) AU2020205000A1 (https=)
BR (1) BR112021013180A2 (https=)
CA (1) CA3125201A1 (https=)
IL (1) IL284461A (https=)
PH (1) PH12021551619A1 (https=)
SG (1) SG11202107246TA (https=)
WO (1) WO2020142780A1 (https=)
ZA (1) ZA202103899B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12419913B2 (en) 2019-02-08 2025-09-23 Dna Twopointo, Inc. Modification of CAR-T cells
WO2025084880A1 (ko) * 2023-10-20 2025-04-24 주식회사 이온셀 Ct83 항원에 결합하는 car-t 세포 및 이의 용도
CN117567650B (zh) * 2024-01-15 2024-04-02 中国人民解放军东部战区总医院 共表达细胞间黏附分子icam2的car-t细胞及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000541A2 (en) * 1996-07-03 1998-01-08 Chiron Corporation Methods for administration of recombinant gene delivery vehicles for treatment of human disease
CA2371216A1 (en) * 1999-04-23 2000-11-02 Centre For Translational Research In Cancer Pseudotyped retroviral vector for gene therapy of cancer
AU2001265187A1 (en) * 2000-05-30 2001-12-11 Baylor College Of Medicine Chimeric viral vectors for gene therapy
US20130266551A1 (en) * 2003-11-05 2013-10-10 St. Jude Children's Research Hospital, Inc. Chimeric receptors with 4-1bb stimulatory signaling domain
PH12013501201A1 (en) * 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
GB201322798D0 (en) * 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
US11230719B2 (en) * 2014-03-26 2022-01-25 Denovo Biopharma Llc Retroviral vector having immune-stimulating activity
AU2016243124A1 (en) * 2015-03-27 2017-11-02 University Of Southern California CAR T-cell therapy directed to LHR for the treatment of solid tumors
EP3286225B1 (en) * 2015-04-23 2020-07-01 Baylor College of Medicine Cd5 chimeric antigen receptor for adoptive t cell therapy
CN107708741A (zh) * 2015-06-12 2018-02-16 免疫医疗公司 用嵌合抗原受体(car)构建体和表达car构建体的t细胞(car‑t)或nk细胞(car‑nk)进行的疾病疗法
MA46236A (fr) * 2016-09-14 2019-07-24 Janssen Biotech Inc Récepteurs antigéniques chimériques comprenant des domaines de la fibronectine de type iii spécifiques du bcma, et utilisations correspondantes
CA3068634A1 (en) * 2017-06-30 2019-01-03 Memorial Sloan Kettering Cancer Center Compositions and methods for adoptive cell therapy for cancer

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
JP2022516710A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016200A2 (https=)